Poliscio Analytics LLC
  • Text-to-Speech
  • Daily Alerts
  • Insights
    • Our Insights Articles
    • Project 2025
  • FOIAengine
    • Log In
    • About FOIA Engine
    • Trial User Signup
    • User Support
    • How to Use
  • About
    • About PoliScio
    • Leadership
  • Newsroom
  • Contact
Select Page
WanaLawsuit? WanaBana.

WanaLawsuit? WanaBana.

by John A. Jenkins | Mar 13, 2024 | FDA, FOIA, Law Firms, Non-Profits, Pharmaceuticals

FOIAengine Spotlights a Non-Profit Newsroom and Another Problem for the FDA The Food and Drug Administration was already under fire from Congress and others after hundreds of toddlers in 44 states were poisoned last year by lead-tainted pouches of apple puree and...
For Elon Musk, a Trail of Legal Challenges

For Elon Musk, a Trail of Legal Challenges

by John A. Jenkins | Mar 6, 2024 | FOIA, Litigation, Short-Selling, Stock Market

FOIAengine Previews an April Fool’s Day Courtrooom Grudge Match This week’s story is about two litigation magnets.  One is a household name whose lawsuit against OpenAI dominated the news a few days ago. That would be Elon Musk.   The other – Aaron Greenspan –...
Hedge Funds Watching Drug Makers

Hedge Funds Watching Drug Makers

by Randy E. Miller | Feb 14, 2024 | FDA, FOIA, Hedge Funds, Litigation, Pharmaceuticals, Short-Selling, Stock Market

FOIAengine Breaks Down the Action Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech, Apellis Pharmaceuticals, Establishment Labs, Catalent and Astellas.  That’s according to...
A Raft of Document Requests from the FTC and Media

A Raft of Document Requests from the FTC and Media

by John A. Jenkins | Feb 7, 2024 | FOIA, FTC, Litigation

FOIAengine: Who’s Asking What, and Why? Days after the Federal Trade Commission launched an investigation of the five biggest players in artificial intelligence, Lina Khan was on a charm offensive aimed at winning the confidence of her biggest enemies on Wall...
“The Assassin” Strike Again

“The Assassin” Strike Again

by John A. Jenkins | Jan 31, 2024 | FDA, FOIA, SEC, Short-Selling, Stock Market

FOIAengine:  Short Seller Fahmi Quadir Goes for Another Kill To keep a nickname like “the Assassin,” the killer better not miss. By the time short seller Fahmi Quadir was scheduled to take the stage on January 30 at a big investment conference in Miami Beach, she had...
A Gambit to Allow Covid Vaccine Lawsuits

A Gambit to Allow Covid Vaccine Lawsuits

by Randy E. Miller | Jan 24, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals

In FOIAengine, a Law Firm’s Strategy Takes Shape When we tallied the hundreds of thousands of Freedom of Information Act requests filed with the federal government last year, one law firm stood out. According to PoliScio Analytics’ competitive-intelligence database...
« Older Entries
Next Entries »
  • Terms of Service
  • Privacy Policy
Copyright 2025 PoliScio Analytics LLC